DCLK1 and renal cell carcinoma: First, in our studies, immunoblotting with phospho-specific antibody for Serine 337 indicated that 10 μM DCLK1-IN-1 treatment strongly inhibits DCLK1 phosphorylation without affecting total DCLK1 protein levels in RCC cells (Figure 1A and Figure 2A).